Daniel Troy is Director of NRX Pharmaceuticals, Inc.. Currently has a direct ownership of 43,093 shares of NRXP, which is worth approximately $65,070. The most recent transaction as insider was on May 24, 2021, when has been sold 43,093 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.1K
0% 3M change
0% 12M change
Total Value Held $65,070

Daniel Troy Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 24 2021
BUY
Grant, award, or other acquisition
-
43,093 Added 50.0%
43,093 Common Stock
DT

Daniel Troy

Director
Wilmington, DE

Track Institutional and Insider Activities on NRXP

Follow NRX Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRXP shares.

Notify only if

Insider Trading

Get notified when an Nrx Pharmaceuticals, Inc. insider buys or sells NRXP shares.

Notify only if

News

Receive news related to NRX Pharmaceuticals, Inc.

Track Activities on NRXP